Technical Symposium

Biopharma Solutions Technical Symposium: Advancements in Biopharma & Cell Culture Technology

Join us for an insightful workshop focusing on innovative biopharma solutions, including advancements in therapeutic protein therapy applications. This event is designed for professionals in the biopharmaceutical industry to explore advancements in cell culture ingredients and technology to enhance their understanding of bioprocess optimization.

Why Attend?

This is a unique opportunity to learn from academic and industry experts, engage in valuable discussions, and connect with peers who are shaping the future of biopharma.

Key learnings for participants

  • Innovative Approaches: Learn about advancements in cell culture and media development for improved efficiency.
  • New Product Launches: Explore cutting-edge products shaping the future of biopharma.
  • Networking Opportunities: Connect with industry leaders and peers to foster collaboration.
  • Interactive Discussions: Address key challenges and future directions in biopharma.

 


Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.


Technical Symposium details

238 Main Street
Cambridge, MA (located at Kendall/M.I.T. MBTA stop) 
USA

English

on-site

Free of charge

October 23, 2026​

Register now

Our experts at the symposium

Registration

Fill out the form to register for the technical symposium:

Agenda

The symposium will start at 10 a.m. on Friday, October 23, 2026, and finish at 3:30 p.m. on the same day. To see the detailed workshop program please click here.

10:00 am
Registration
10:15 am
Welcome & Introduction
Jordan Ryan | Associate Director Business Development, Biopharma Solutions @ Evonik Health Care
10:30 am
Effects of dipeptide media supplements on product quality for CHO cells
Prof. Sarah Harcum | Department of Bioengineering @ Clemson University
11:15 am
Performance Solutions for Biomanufacturing: From Protein Expression to Drug Formulation
Dr. Zach Demorest | Director, Biopharma Solutions @ Evonik Health Care
11:45 am
Lunch
12:45 pm
TBA
Dr. Jacqueline Wolfrum | Codirector of Biomanufacturing @ MIT Center for Biomedical Innovation
01:15 pm
Peptide-mediated sustained amino-acid release enables metabolic control and improves productivity in intensified fed-batch cultures
Dr. Jianfa Ou | Principal Scientist@ Evonik Health Care
01:45 pm
Break
02:00 pm
Media Innovation and Process Intensification Strategies for Enhanced Fed-Batch Cell Culture
Dr. Pranay Ladiwala | Senior Scientist, Cell Culture Platform Development @ Sanofi
02:45 pm
Lab Tour & Networking
03:30 pm
End
09:00 am
Welcome & Introduction
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
09:10 am
Heterogeneous Catalysis in Flow Chemistry & Nickel Foam
Trevor Murray | Strategic Account Executive – Life Sciences @ Basetwo AI
10:30 am
Break
Trevor Murray | Strategic Account Executive – Life Sciences @ Basetwo AI
10:45 am
Overcoming the Selectivity Issue in a Nickel Catalyzed Batch Hydrogenation
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
11:30 am
Using Interfacial Charge Separation to Understand and Control Catalysis
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
12:15 pm
Lunch & Networking
Eric Neuffer | Drug Substance Business Head – New Business Development @ Evonik Health Care
01:15 pm
Heterogeneous Catalysis in CC Coupling
Maxim Radzhabov | Project Leader @ Evonik Catalysts
01:15 pm
Heterogeneous Catalysis in CC Coupling
Maxim Radzhabov | Project Leader @ Evonik Catalysts
01:15 pm
Heterogeneous Catalysis in CC Coupling
Maxim Radzhabov | Project Leader @ Evonik Catalysts

Disclaimer

Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.

Questions?

Questions

Likhitha Bingham
Marketing Analyst
+1 256-783-9347

  • Evonik on social media